JP2009504742A - シリルアミンで改質されたナノ粒子状キャリヤ - Google Patents

シリルアミンで改質されたナノ粒子状キャリヤ Download PDF

Info

Publication number
JP2009504742A
JP2009504742A JP2008527016A JP2008527016A JP2009504742A JP 2009504742 A JP2009504742 A JP 2009504742A JP 2008527016 A JP2008527016 A JP 2008527016A JP 2008527016 A JP2008527016 A JP 2008527016A JP 2009504742 A JP2009504742 A JP 2009504742A
Authority
JP
Japan
Prior art keywords
composition
core
colloid
particles
silylamine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2008527016A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009504742A5 (https=
Inventor
フランシス ブリングレー，ジョセフ
アレックス チャオ，ティーチェン
Original Assignee
ケアストリーム ヘルス，インコーポレイティド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ケアストリーム ヘルス，インコーポレイティド filed Critical ケアストリーム ヘルス，インコーポレイティド
Publication of JP2009504742A publication Critical patent/JP2009504742A/ja
Publication of JP2009504742A5 publication Critical patent/JP2009504742A5/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C03—GLASS; MINERAL OR SLAG WOOL
    • C03C—CHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MATERIALS
    • C03C17/00—Surface treatment of glass, not in the form of fibres or filaments, by coating
    • C03C17/28—Surface treatment of glass, not in the form of fibres or filaments, by coating with organic material
    • C03C17/30—Surface treatment of glass, not in the form of fibres or filaments, by coating with organic material with silicon-containing compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0032—Methine dyes, e.g. cyanine dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
    • A61K49/0069—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form
    • A61K49/0089—Particulate, powder, adsorbate, bead, sphere
    • A61K49/0091—Microparticle, microcapsule, microbubble, microsphere, microbead, i.e. having a size or diameter higher or equal to 1 micrometer
    • A61K49/0093—Nanoparticle, nanocapsule, nanobubble, nanosphere, nanobead, i.e. having a size or diameter smaller than 1 micrometer, e.g. polymeric nanoparticle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • C—CHEMISTRY; METALLURGY
    • C03—GLASS; MINERAL OR SLAG WOOL
    • C03C—CHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MATERIALS
    • C03C11/00—Multi-cellular glass ; Porous or hollow glass or glass particles
    • C03C11/002—Hollow glass particles
    • C—CHEMISTRY; METALLURGY
    • C03—GLASS; MINERAL OR SLAG WOOL
    • C03C—CHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MATERIALS
    • C03C4/00—Compositions for glass with special properties
    • C03C4/0007—Compositions for glass with special properties for biologically-compatible glass
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5115—Inorganic compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2991—Coated
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2991—Coated
    • Y10T428/2993—Silicic or refractory material containing [e.g., tungsten oxide, glass, cement, etc.]
    • Y10T428/2995—Silane, siloxane or silicone coating

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Geochemistry & Mineralogy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials Engineering (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2008527016A 2005-08-18 2006-08-11 シリルアミンで改質されたナノ粒子状キャリヤ Withdrawn JP2009504742A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/206,362 US20070292688A1 (en) 2005-08-18 2005-08-18 Silylamine modified nanoparticulate carriers
PCT/US2006/031397 WO2007021946A2 (en) 2005-08-18 2006-08-11 Silylamine modified nanoparticulate carriers

Publications (2)

Publication Number Publication Date
JP2009504742A true JP2009504742A (ja) 2009-02-05
JP2009504742A5 JP2009504742A5 (https=) 2009-08-06

Family

ID=37758211

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008527016A Withdrawn JP2009504742A (ja) 2005-08-18 2006-08-11 シリルアミンで改質されたナノ粒子状キャリヤ

Country Status (6)

Country Link
US (1) US20070292688A1 (https=)
EP (1) EP1915423A2 (https=)
JP (1) JP2009504742A (https=)
CN (1) CN101263191A (https=)
AU (1) AU2006279863A1 (https=)
WO (1) WO2007021946A2 (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020110481A1 (ja) * 2018-11-30 2020-06-04 パナソニックＩｐマネジメント株式会社 複合体及び検出装置
JP2022501064A (ja) * 2018-11-09 2022-01-06 アルブータス・バイオファーマー・コーポレイション ケイ素を含有するカチオン性脂質

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE536993T1 (de) 2002-01-02 2011-12-15 Visen Medical Inc Aminfunktionalisierte superparamagnetisierte nanoteilchen für die synthese von biokonjugaten
WO2007136413A2 (en) * 2005-12-22 2007-11-29 Visen Medical, Inc. Biocompatible fluorescent metal oxide nanoparticles
EP2030632A1 (en) * 2007-09-03 2009-03-04 UMC Utrecht Holding B.V. A carrier particle for use in bio-applications
AU2009248810B2 (en) * 2008-05-23 2013-12-05 The Regents Of The University Of Michigan Nanoemulsion vaccines
EP2293814A4 (en) * 2008-05-23 2013-02-13 Univ Michigan NANOEMULSION AGENTS
EP2349209A2 (en) 2008-09-26 2011-08-03 Nanobio Corporation Nanoemulsion therapeutic compositions and methods of using the same
JP5203132B2 (ja) * 2008-10-21 2013-06-05 古河電気工業株式会社 架橋性官能基を粒子表面に有するシリカ粒子の製造方法、架橋性官能基を粒子表面に有するシリカ粒子、前記シリカ粒子のコロイド、前記シリカ粒子を用いた複合粒子、及び前記複合粒子の製造方法
IT1398194B1 (it) 2008-10-22 2013-02-14 Univ Degli Studi Torino Cianina funzionalizzata con braccio di legame silanico, procedimento per la sua preparazione e suoi usi
US9399075B2 (en) 2008-12-29 2016-07-26 General Electric Company Nanoparticle contrast agents for diagnostic imaging
ES2647567T3 (es) * 2008-12-29 2017-12-22 General Electric Company Agentes de contraste de nanopartículas para el diagnóstico por imágenes
BRPI1014031A2 (pt) * 2009-06-16 2018-02-20 Univ Michigan Regents vacinas de nanoemulsão
CN107375214B (zh) * 2017-07-27 2020-07-28 重庆医科大学 一种载药的叶酸修饰蒙脱石纳米制剂及其制备方法
CN109540859B (zh) * 2018-11-27 2021-02-09 上海交通大学 一种水体中抗生素的分析和含量预测方法
CN116603462B (zh) * 2023-05-22 2025-06-06 哈尔滨理工大学 一种HGMs@Al2O3复合微球及制备方法和在构筑三维隔热结构水性隔热涂料中的应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5760126A (en) * 1996-12-20 1998-06-02 Minnesota Mining And Manufacturing Company Aqueous fluorochemical compositions and abrasion-resistant coatings therefrom
WO1998051435A1 (en) * 1997-05-14 1998-11-19 Weixin Tang Fully-coated, uniform-sized metallic particles
US6692123B2 (en) * 2001-08-31 2004-02-17 Eastman Kodak Company Ink jet printing method
US7189417B2 (en) * 2002-05-01 2007-03-13 The Trustees Of The University Of Pennsylvania Nanometer-sized carrier medium
GB0216780D0 (en) * 2002-07-19 2002-08-28 Bradford Particle Design Ltd Methods of particle formation
US20040115239A1 (en) * 2002-09-20 2004-06-17 Shastri Venkatram P. Engineering of material surfaces
US7109247B2 (en) * 2003-05-30 2006-09-19 3M Innovative Properties Company Stabilized particle dispersions containing nanoparticles
US7459146B2 (en) * 2003-05-30 2008-12-02 3M Innovative Properties Company Stabilized aerosol dispersions
US20040242729A1 (en) * 2003-05-30 2004-12-02 3M Innovative Properties Company Stabilized particle dispersions containing surface-modified inorganic nanoparticles
US20050014851A1 (en) * 2003-07-18 2005-01-20 Eastman Kodak Company Colloidal core-shell assemblies and methods of preparation
US6890610B2 (en) * 2003-07-18 2005-05-10 Eastman Kodak Company Inkjet recording element
US20060293396A1 (en) * 2005-01-14 2006-12-28 Eastman Kodak Company Amine polymer-modified nanoparticulate carriers

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022501064A (ja) * 2018-11-09 2022-01-06 アルブータス・バイオファーマー・コーポレイション ケイ素を含有するカチオン性脂質
US12350383B2 (en) 2018-11-09 2025-07-08 Arbutus Biopharma Corporation Cationic lipids containing silicon
WO2020110481A1 (ja) * 2018-11-30 2020-06-04 パナソニックＩｐマネジメント株式会社 複合体及び検出装置
US12006458B2 (en) 2018-11-30 2024-06-11 Panasonic Intellectual Property Management Co., Ltd. Complex and detection device

Also Published As

Publication number Publication date
US20070292688A1 (en) 2007-12-20
WO2007021946A3 (en) 2007-06-07
WO2007021946A2 (en) 2007-02-22
EP1915423A2 (en) 2008-04-30
CN101263191A (zh) 2008-09-10
AU2006279863A1 (en) 2007-02-22

Similar Documents

Publication Publication Date Title
US20080241266A1 (en) Amine polymer-modified nanoparticulate carriers
US7541017B2 (en) Amine polymer-modified nanoparticulate carriers
Karakoçak et al. Hyaluronan-conjugated carbon quantum dots for bioimaging use
JP2009504742A (ja) シリルアミンで改質されたナノ粒子状キャリヤ
EP2000150B1 (en) Titanium oxide complex particle, dispersion solution of the particle, and process for production of the particle
US12377174B2 (en) Magnetic nanoparticles functionalized with N-(3,4-dihydroxyphenethyl)dodecanamide, production and use thereof
US8491908B2 (en) Composite particle, contrast agent for photoacoustic imaging, and method for producing the composite particle
US20140107738A1 (en) Magnetic particles
WO2008036117A2 (en) Nanogel contrast agents for optical molecular imaging
Zhang et al. Optimizing the polymer cloak for upconverting nanoparticles: an evaluation of bioactivity and optical performance
KR20190062320A (ko) 글루타치온―ｓ―전이효소 및 표적 세포 또는 표적 단백질 결합능을 갖는 단백질을 포함하는 융합 단백질 및 이의 용도
Nakamura Biomedical applications of organosilica nanoparticles toward theranostics.
KR101797829B1 (ko) 표면전하 전환형 약물전달용 나노입자 및 이의 제조방법
Wang et al. A pH-sensitive theranostics system based on doxorubicin conjugated with the comb-shaped polymer coating of quantum dots
Zayed et al. Growth factor loaded functionalized gold nanoparticles as potential targeted treatment for acute renal failure
WO2025172829A1 (en) Synthesis of chimeric peptosomes hybridized with rod-shaped gold nanoparticles and aptamer-targeted for breast cancer therapy and imaging
Duceppe et al. Design and development of light-sensitive chitosan-based nanocarriers for gene delivery
EP4005558A1 (en) Anticancer agent and method for preparation of porous silica particle
Khullar et al. Hemolytic Assay of Biocompatible Nanomaterials in Drug Delivery Systems
Lin Multifunctional Nanoparticles for Anticancer Gene Delivery and Tumor Monitoring
Kostiv Design and characterization of advanced polymer-coated upconversion nanoparticles
AU2008202025A1 (en) Magnetic nanoparticles
HK1129567B (en) Fluorescent nanoparticles
HK1129567A1 (zh) 荧光纳米微粒

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090616

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20090616

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20091218